These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 31609143)
1. Downregulation of the circadian Period family genes is positively correlated with poor head and neck squamous cell carcinoma prognosis. Li YY; Jin F; Zhou JJ; Yu F; Duan XF; He XY; Wang R; Wu WL; Long JH; Luo XL Chronobiol Int; 2019 Dec; 36(12):1723-1732. PubMed ID: 31609143 [TBL] [Abstract][Full Text] [Related]
2. Circadian (De)regulation in Head and Neck Squamous Cell Carcinoma. Rahman S; Kraljević Pavelić S; Markova-Car E Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31151182 [TBL] [Abstract][Full Text] [Related]
3. Combined expression and prognostic significance of PPFIA1 and ALG3 in head and neck squamous cell carcinoma. Zhou H; Cao T; Li WP; Wu G Mol Biol Rep; 2019 Jun; 46(3):2693-2701. PubMed ID: 30805892 [TBL] [Abstract][Full Text] [Related]
4. Altered expression of circadian clock genes in head and neck squamous cell carcinoma. Hsu CM; Lin SF; Lu CT; Lin PM; Yang MY Tumour Biol; 2012 Feb; 33(1):149-55. PubMed ID: 22081375 [TBL] [Abstract][Full Text] [Related]
5. Expression level of PD-L1 is involved in ALDH1A1-mediated poor prognosis in patients with head and neck squamous cell carcinoma. Zhou AL; Wang X; Yu W; Yang L; Wei F; Sun Q; Wang Y; Kou F; Dong R; Ren X; Zhang X Pathol Res Pract; 2020 Sep; 216(9):153093. PubMed ID: 32825960 [TBL] [Abstract][Full Text] [Related]
6. High expression of GPNMB predicts poor prognosis in head and neck squamous cell carcinoma. Li H; Xiao Y; Wu CC; Yang LL; Cao LY; Chen DR; Zhou JJ; Zhang WF; Sun ZJ Histol Histopathol; 2019 Jul; 34(7):803-810. PubMed ID: 30632601 [TBL] [Abstract][Full Text] [Related]
7. Identification of CCT3 as a prognostic factor and correlates with cell survival and invasion of head and neck squamous cell carcinoma. Wang Y; Liu P; Zhang Z; Wang J; Cheng Z; Fan C Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34505628 [TBL] [Abstract][Full Text] [Related]
8. PER1 and CLOCK: potential circulating biomarkers for head and neck squamous cell carcinoma. Hsu CM; Lin PM; Lai CC; Lin HC; Lin SF; Yang MY Head Neck; 2014 Jul; 36(7):1018-26. PubMed ID: 23784787 [TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of the expression and prognosis for CDCAs in head and neck squamous cell carcinoma. Wu ZH; Fang M; Zhou Y PLoS One; 2020; 15(7):e0236678. PubMed ID: 32716971 [TBL] [Abstract][Full Text] [Related]
10. BP180 Is a Prognostic Factor in Head and Neck Squamous Cell Carcinoma. Meng X; Matsumoto F; Mori T; Miura N; Ino Y; Onidani K; Kobayashi K; Matsuzaki Y; Yoshimoto S; Ikeda K; Honda K Anticancer Res; 2021 Feb; 41(2):1089-1099. PubMed ID: 33517320 [TBL] [Abstract][Full Text] [Related]
11. Elevated expression of iASPP in head and neck squamous cell carcinoma and its clinical significance. Liu Z; Zhang X; Huang D; Liu Y; Zhang X; Liu L; Li G; Dai Y; Tan H; Xiao J; Tian Y Med Oncol; 2012 Dec; 29(5):3381-8. PubMed ID: 22815155 [TBL] [Abstract][Full Text] [Related]
12. Loss of the clock gene PER2 is associated with cancer development and altered expression of important tumor-related genes in oral cancer. Xiong H; Yang Y; Yang K; Zhao D; Tang H; Ran X Int J Oncol; 2018 Jan; 52(1):279-287. PubMed ID: 29115399 [TBL] [Abstract][Full Text] [Related]
13. Aberrant expression of Per1, Per2 and Per3 and their prognostic relevance in non-small cell lung cancer. Liu B; Xu K; Jiang Y; Li X Int J Clin Exp Pathol; 2014; 7(11):7863-71. PubMed ID: 25550826 [TBL] [Abstract][Full Text] [Related]
14. Rh type C-glycoprotein functions as a novel tumor suppressor gene by inhibiting tumorigenicity and metastasis in head and neck squamous cell carcinoma. Xu W; Zou H; Wei Z; Song C; Tang C; Yin X; Wang Y; Han S; Cai Y; Han W Aging (Albany NY); 2019 Jun; 11(11):3601-3623. PubMed ID: 31170090 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of BASP1 Indicates a Poor Prognosis in Head and Neck Squamous Cell Carcinoma. Jaikumarr Ram A; Girija As S; Jayaseelan VP; Arumugam P Asian Pac J Cancer Prev; 2020 Nov; 21(11):3435-3439. PubMed ID: 33247706 [TBL] [Abstract][Full Text] [Related]
16. Elevated exosomal lysyl oxidase like 2 is a potential biomarker for head and neck squamous cell carcinoma. Sanada T; Islam A; Kaminota T; Kirino Y; Tanimoto R; Yoshimitsu H; Yano H; Mizuno Y; Okada M; Mitani S; Ugumori T; Tanaka J; Hato N Laryngoscope; 2020 May; 130(5):E327-E334. PubMed ID: 31219623 [TBL] [Abstract][Full Text] [Related]
17. Downregulation of nuclear ING3 expression and translocalization to cytoplasm promotes tumorigenesis and progression in head and neck squamous cell carcinoma (HNSCC). Li X; Zhang Q; Zhang M; Luo Y; Fu Y Histol Histopathol; 2020 Jul; 35(7):681-690. PubMed ID: 31886514 [TBL] [Abstract][Full Text] [Related]
18. A Study on the Correlations of the miR-31 Expression with the Pathogenesis and Prognosis of Head and Neck Squamous Cell Carcinoma. Qiang H; Zhan X; Wang W; Cheng Z; Ma S; Jiang C Cancer Biother Radiopharm; 2019 Apr; 34(3):189-195. PubMed ID: 30628842 [TBL] [Abstract][Full Text] [Related]
19. Oncogenic Role of ZFAS1 lncRNA in Head and Neck Squamous Cell Carcinomas. Kolenda T; Guglas K; Kopczyńska M; Teresiak A; Bliźniak R; Mackiewicz A; Lamperska K; Mackiewicz J Cells; 2019 Apr; 8(4):. PubMed ID: 31010087 [TBL] [Abstract][Full Text] [Related]
20. Analysis of the relationship between GLUT family in the progression and immune infiltration of head and neck squamous carcinoma. Li B Diagn Pathol; 2023 Aug; 18(1):88. PubMed ID: 37542344 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]